Medicines Commission of the Agency for Medicines and Medical Devices (AMDM) has authorized 24 medicinal products, 13 of which are new on the market. The other 11 were repeatedly authorized, IPN reports.

According to the AMDM, among the newly authorized drugs are Bendamustine, prescribed to treat certain forms of cancer, and Troxerutin, for the relief of chronic venous disorders.

Included in the lot of repeat approval are pharmaceuticals such as Hydrocortisone, to suppress inflammatory or immune reactions, and Rosuvastatin-LF, to treat hypercholesterolemia and prevent major cardiovascular events.

The full list of medicines authorized in Moldova is available on the AMDM website.